Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Management and survival outcomes of desmoplastic small round cell tumor: a retrospective cohort study from a tertiary cancer center.

BMC cancer·2025

Same author

Survival and prognostic factors of childhood Ewing sarcoma - Experience from a cancer center in South India.

Indian journal of cancer·2025

Same author

Outcome of Reconstruction with Irradiated Tumour Bone in Paediatric Malignant Bone Tumours.

Indian journal of surgical oncology·2025

Same author

Eosinophilic dermatitis in a patient with chronic lymphocytic leukemia.

Indian journal of pathology & microbiology·2025

Same author

Ewing's sarcoma in adolescents and adults - 10-year experience from a tertiary cancer center in India.

Journal of cancer research and therapeutics·2024

Same author

Initial presentation of hepatocellular carcinoma as pharyngeal mass mimicking advanced hypopharyngeal carcinoma.

Journal of cancer research and therapeutics·2024

Search research articles

Related Experiment Video

Updated: Jun 29, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Telangiectatic Osteosarcoma-A Single-Center Experience.

Geetha Narayanan¹, Sugeeth M Thambi¹, Jayasree Kattoor²

¹Department of Medical Oncology, Regional Cancer Centre, Trivandrum, Kerala, India.

South Asian Journal of Cancer

|December 31, 2025

Summary

Telangiectatic osteosarcoma, a rare bone cancer, shows promising outcomes with multi-modal treatment. Patients treated with chemotherapy and surgery achieved remission, indicating effective management strategies for this osteosarcoma subtype.

Keywords:

bone tumor chemotherapy limb salvage surgery osteosarcoma telangiectatic

More Related Videos

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Related Experiment Videos

Last Updated: Jun 29, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Area of Science:

Oncology
Orthopedic Oncology
Cancer Research

Background:

Telangiectatic osteosarcoma is a rare subtype, comprising less than 4% of osteosarcoma cases.
It presents unique radiographic and pathological features, often mimicking aneurysmal bone cysts.
Understanding its clinical profile and treatment outcomes is crucial for improving patient prognosis.

Purpose of the Study:

To investigate the clinical characteristics of telangiectatic osteosarcoma patients.
To evaluate the treatment outcomes in patients diagnosed with telangiectatic osteosarcoma.
To analyze survival rates and remission status following treatment.

Main Methods:

Retrospective analysis of 13 patients diagnosed with telangiectatic osteosarcoma over 12 years.
Patients received neoadjuvant and/or adjuvant chemotherapy (ifosfamide, doxorubicin, cisplatin).
Treatment included limb-sparing surgery or amputation.

Main Results:

The median age at presentation was 20 years, with a male predominance.
Common sites were the lower femur and upper humerus.
Eight of ten treated patients achieved remission with a median follow-up of 50 months.

Conclusions:

Telangiectatic osteosarcoma, despite its rarity, can be effectively managed with a combination of chemotherapy and surgery.
The observed remission rates suggest a favorable prognosis with current treatment protocols.
Further research into optimizing treatment for this specific osteosarcoma subtype is warranted.